Streetbeat News

Regulatory

IMRN

Immuron Limited has announced the enrollment of the first cohort of 30 participants in a clinical trial to evaluate the efficacy of Travelan to prevent infectious diarrhea caused by ETEC. The company is listed on both the ASX and NASDAQ (IMRN).

Portfolio Pulse from Charles Gross

July 25, 2023 | 9:00 am

STLA

TSLA

Ford Motor Co (F) and Stellantis NV (STLA) have issued the most vehicle recalls in 2023, with Ford leading with 31 recalls affecting over 4.1 million vehicles and Stellantis following with 26 recalls impacting 1.7 million vehicles. Tesla Inc (TSLA) has issued 10 recalls in 2023, impacting approximately 380,000 vehicles.

Portfolio Pulse from Anan Ashraf

July 25, 2023 | 8:50 am

FXI

SPY

China's major state-owned banks were reportedly selling U.S. dollars to buy yuan in spot markets on Tuesday in an attempt to prop up the Chinese currency, according to Reuters.

Portfolio Pulse from Charles Gross

July 25, 2023 | 8:47 am

EWG

VGK

Germany's Ifo Business Climate Index for July came in at 87.3, lower than the estimated 88 and the prior figure of 88.6.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 8:04 am

EWG

VGK

Germany's business expectations for July were reported at 83.5, slightly above the estimated 83.4, but below the prior figure of 83.8.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2023 | 8:03 am

BTCUSD

DOGEUSD

ETHUSD

Dogecoin co-creator Billy Markus has referred to the newly launched cryptocurrency Worldcoin as 'creepy and weird'. The Worldcoin project, led by OpenAI CEO Sam Altman, aims to align economic incentives and human identity by scanning individuals' eyes to generate a unique digital identity. Despite skepticism from Markus and Ethereum co-founder Vitalik Buterin, the increasing interest in AI may provide momentum for the Worldcoin project.

Portfolio Pulse from Mehab Qureshi

July 25, 2023 | 6:11 am

BTCUSD

DOGEUSD

ETHUSD

Major cryptocurrencies traded mixed on Monday, with Bitcoin and Ethereum dropping while Dogecoin spiked. The decline in Bitcoin's volume dominance is attributed to a spike in altcoin trading, fueled by the Ripple ruling and regulatory adjustments. Ethereum co-founder Vitalik Buterin expressed concerns about the World Coin project. The global crypto market capitalization stands at $1.17 trillion. Analysts predict a potential dip for Bitcoin before it reaches the $100K mark.

Portfolio Pulse from Mehab Qureshi

July 25, 2023 | 2:45 am

GILD

Gilead Sciences, Inc. (NASDAQ:GILD) presented new data reinforcing the efficacy, safety, and tolerability profile of lenacapavir, a twice-yearly injectable HIV treatment. The data from the Phase 2/3 CAPELLA trial showed favorable patient-reported outcomes and high rates of virologic suppression. The findings underscore lenacapavir's potential impact on the future of coordinated HIV clinical care.

Portfolio Pulse from Happy Mohamed

July 24, 2023 | 11:18 pm

NIO

CYVN Investments RSC Ltd has disclosed a 7.7% stake in NIO Inc. as of July 12, 2023, according to a 13D filing with the SEC.

Portfolio Pulse from Happy Mohamed

July 24, 2023 | 11:11 pm

CYBN

DRUG

PMBHF

Cybin (NYSE:CYBN) has completed dosing on five of six participant cohorts in its ongoing Phase 2 trial for the treatment of Major Depressive Disorder (MDD). Bright Minds Biosciences (NASDAQ:DRUG) has completed its three-part Phase 1 clinical trial of BMB-101, a novel treatment for refractory epilepsies, psychosis, addiction and impulse control disorders. PharmAla Biotech Holdings (OTC:PMBHF) has received written guidance from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to proceed to clinical trials with MDMA analog ALA-002.

Portfolio Pulse from Lara Goldstein

July 24, 2023 | 9:44 pm